U.S. markets closed

Dicerna Pharmaceuticals, Inc. (DRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.85+0.25 (+1.28%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
89,591
23,904
6,176
2,277
295
Operating Expense
222,283
152,090
67,396
62,864
60,043
Operating Income
-132,692
-128,186
-61,220
-60,587
-59,748
Net Non Operating Interest Income Expense
7,712
7,534
1,499
539
235
Other Income Expense
-
193
-29,132
-
-
Pretax Income
-124,772
-120,459
-88,853
-60,048
-59,513
Net Income Common Stockholders
-124,772
-120,459
-88,853
-60,048
-59,513
Diluted NI Available to Com Stockholders
-124,772
-120,459
-88,853
-60,048
-59,513
Basic EPS
-
-0.0018
-0.0016
-0.0037
-0.0029
Diluted EPS
-
-0.0018
-0.0016
-0.0037
-0.0029
Basic Average Shares
-
68,428
55,616
21,917
20,720
Diluted Average Shares
-
68,428
55,616
21,917
20,720
Total Operating Income as Reported
-132,692
-128,186
-90,352
-60,587
-59,748
Total Expenses
222,283
152,090
67,396
62,864
60,043
Net Income from Continuing & Discontinued Operation
-124,772
-120,459
-88,853
-60,048
-59,513
Normalized Income
-124,772
-120,459
-59,721
-60,048
-59,513
Interest Income
7,725
7,537
2,102
539
235
Interest Expense
13
3
603
-
0
Net Interest Income
7,712
7,534
1,499
539
235
EBIT
-124,759
-120,456
-88,250
-60,587
-59,513
EBITDA
-122,978
-
-
-
-
Reconciled Depreciation
1,781
1,254
774
778
840
Net Income from Continuing Operation Net Minority Interest
-124,772
-120,459
-88,853
-60,048
-59,513
Total Unusual Items Excluding Goodwill
-
0
-29,132
-
0
Total Unusual Items
-
0
-29,132
-
0
Normalized EBITDA
-122,978
-119,202
-58,344
-59,809
-58,673
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0